| 1A8I | A: | SPIROHYDANTOIN INHIBITOR OF GLYCOGEN PHOSPHORYLASE |
| 1ABB | A:; B:; C:; D: | CONTROL OF PHOSPHORYLASE B CONFORMATION BY A MODIFIED COFACTOR: CRYSTALLOGRAPHIC STUDIES ON R-STATE GLYCOGEN PHOSPHORYLASE RECONSTITUTED WITH PYRIDOXAL 5'-DIPHOSPHATE |
| 1AXR | A: | COOPERATIVITY BETWEEN HYDROGEN-BONDING AND CHARGE-DIPOLE INTERACTIONS IN THE INHIBITION OF BETA-GLYCOSIDASES BY AZOLOPYRIDINES: EVIDENCE FROM A STUDY WITH GLYCOGEN PHOSPHORYLASE B |
| 1B4D | A: | AMIDOCARBAMATE INHIBITOR OF GLYCOGEN PHOSPHORYLASE |
| 1BX3 | A: | EFFECTS OF COMMONLY USED CRYOPROTECTANTS ON GLYCOGEN PHOSPHORYLASE ACTIVITY AND STRUCTURE |
| 1C50 | A: | IDENTIFICATION AND STRUCTURAL CHARACTERIZATION OF A NOVEL ALLOSTERIC BINDING SITE OF GLYCOGEN PHOSPHORYLASE B |
| 1C8K | A: | FLAVOPIRIDOL INHIBITS GLYCOGEN PHOSPHORYLASE BY BINDING AT THE INHIBITOR SITE |
| 1C8L | A: | SYNERGISTIC INHIBITION OF GLYCOGEN PHOSPHORYLASE A BY A POTENTIAL ANTIDIABETIC DRUG AND CAFFEINE |
| 1E1Y | A: | FLAVOPIRIDOL INHIBITS GLYCOGEN PHOSPHORYLASE BY BINDING AT THE INHIBITOR SITE |
| 1FS4 | A: | STRUCTURES OF GLYCOGEN PHOSPHORYLASE-INHIBITOR COMPLEXES AND THE IMPLICATIONS FOR STRUCTURE-BASED DRUG DESIGN |
| 1FTQ | A: | STRUCTURES OF GLYCOGEN PHOSPHORYLASE-INHIBITOR COMPLEXES AND THE IMPLICATIONS FOR STRUCTURE-BASED DRUG DESIGN |
| 1FTW | A: | STRUCTURES OF GLYCOGEN PHOSPHORYLASE-INHIBITOR COMPLEXES AND THE IMPLICATIONS FOR STRUCTURE-BASED DRUG DESIGN |
| 1FTY | A: | STRUCTURES OF GLYCOGEN PHOSPHORYLASE-INHIBITOR COMPLEXES AND THE IMPLICATIONS FOR STRUCTURE-BASED DRUG DESIGN |
| 1FU4 | A: | STRUCTURES OF GLYCOGEN PHOSPHORYLASE-INHIBITOR COMPLEXES AND THE IMPLICATIONS FOR STRUCTURE-BASED DRUG DESIGN |
| 1FU7 | A: | STRUCTURES OF GLYCOGEN PHOSPHORYLASE-INHIBITOR COMPLEXES AND THE IMPLICATIONS FOR STRUCTURE-BASED DRUG DESIGN |
| 1FU8 | A: | STRUCTURES OF GLYCOGEN PHOSPHORYLASE-INHIBITOR COMPLEXES AND THE IMPLICATIONS FOR STRUCTURE-BASED DRUG DESIGN |
| 1GFZ | A: | FLAVOPIRIDOL INHIBITS GLYCOGEN PHOSPHORYLASE BY BINDING AT THE INHIBITOR SITE |
| 1GG8 | A: | DESIGN OF INHIBITORS OF GLYCOGEN PHOSPHORYLASE: A STUDY OF ALPHA-AND BETA-C-GLUCOSIDES AND 1-THIO-BETA-D-GLUCOSE COMPOUNDS |
| 1GGN | A: | STRUCTURES OF GLYCOGEN PHOSPHORYLASE-INHIBITOR COMPLEXES AND THE IMPLICATIONS FOR STRUCTURE-BASED DRUG DESIGN |
| 1GPA | A:; B:; C:; D: | STRUCTURAL MECHANISM FOR GLYCOGEN PHOSPHORYLASE CONTROL BY PHOSPHORYLATION AND AMP |
| 1GPB | A: | GLYCOGEN PHOSPHORYLASE B: DESCRIPTION OF THE PROTEIN STRUCTURE |
| 1GPY | A: | CRYSTALLOGRAPHIC BINDING STUDIES ON THE ALLOSTERIC INHIBITOR GLUCOSE-6-PHOSPHATE TO T STATE GLYCOGEN PHOSPHORYLASE B |
| 1H5U | A: | THE 1.76 A RESOLUTION CRYSTAL STRUCTURE OF GLYCOGEN PHOSPHORYLASE B COMPLEXED WITH GLUCOSE AND CP320626, A POTENTIAL ANTIDIABETIC DRUG |
| 1HLF | A: | BINDING OF GLUCOPYRANOSYLIDENE-SPIRO-THIOHYDANTOIN TO GLYCOGEN PHOSPHORYLASE B: KINETIC AND CRYSTALLOGRAPHIC STUD |
| 1K06 | A: | CRYSTALLOGRAPHIC BINDING STUDY OF 100 MM N-BENZOYL-N'-BETA-D-GLUCOPYRANOSYL UREA TO GLYCOGEN PHOSPHORYLASE B |
| 1K08 | A: | CRYSTALLOGRAPHIC BINDING STUDY OF 10 MM N-BENZOYL-N'-BETA-D-GLUCOPYRANOSYL UREA TO GLYCOGEN PHOSPHORYLASE B |
| 1KTI | A: | BINDING OF 100 MM N-ACETYL-N'-BETA-D-GLUCOPYRANOSYL UREA TO GLYCOGEN PHOSPHORYLASE B: KINETIC AND CRYSTALLOGRAPHIC STUDIES |
| 1LWN | A: | CRYSTAL STRUCTURE OF RABBIT MUSCLE GLYCOGEN PHOSPHORYLASE A IN COMPLEX WITH A POTENTIAL HYPOGLYCAEMIC DRUG AT 2.0 A RESOLUTION |
| 1LWO | A: | CRYSTAL STRUCTURE OF RABBIT MUSCLE GLYCOGEN PHOSPHORYLASE A IN COMPLEX WITH A POTENTIAL HYPOGLYCAEMIC DRUG AT 2.0 A RESOLUTION |
| 1NOI | A:; B:; C:; D: | COMPLEX OF GLYCOGEN PHOSPHORYLASE WITH A TRANSITION STATE ANALOGUE NOJIRIMYCIN TETRAZOLE AND PHOSPHATE IN THE T AND R STATES |
| 1NOJ | A: | COMPLEX OF GLYCOGEN PHOSPHORYLASE WITH A TRANSITION STATE ANALOGUE NOJIRIMYCIN TETRAZOLE AND PHOSPHATE IN THE T STATE |
| 1NOK | A: | COMPLEX OF GLYCOGEN PHOSPHORYLASE WITH A TRANSITION STATE ANALOGUE NOJIRIMYCIN TETRAZOLE AND PHOSPHATE IN THE T STATE |
| 1P29 | A: | CRYSTAL STRUCTURE OF GLYCOGEN PHOSPHORYLASE B IN COMPLEX WITH MALTOPENTAOSE |
| 1P2B | A: | CRYSTAL STRUCTURE OF GLYCOGEN PHOSPHORYLASE B IN COMPLEX WITH MALTOHEPTAOSE |
| 1P2D | A: | CRYSTAL STRUCTURE OF GLYCOGEN PHOSPHORYLASE B IN COMPLEX WITH BETA CYCLODEXTRIN |
| 1P2G | A: | CRYSTAL STRUCTURE OF GLYCOGEN PHOSPHORYLASE B IN COMPLEX WITH GAMMA CYCLODEXTRIN |
| 1P4G | A: | CRYSTAL STRUCTURE OF GLYCOGEN PHOSPHORYLASE B IN COMPLEX WITH C-(1-AZIDO-ALPHA-D-GLUCOPYRANOSYL)FORMAMIDE |
| 1P4H | A: | CRYSTAL STRUCTURE OF GLYCOGEN PHOSPHORYLASE B IN COMPLEX WITH C-(1-ACETAMIDO-ALPHA-D-GLUCOPYRANOSYL) FORMAMIDE |
| 1P4J | A: | CRYSTAL STRUCTURE OF GLYCOGEN PHOSPHORYLASE B IN COMPLEX WITH C-(1-HYDROXY-BETA-D-GLUCOPYRANOSYL)FORMAMIDE |
| 1PYG | A:; B:; C:; D: | STRUCTURAL BASIS FOR THE ACTIVATION OF GLYCOGEN PHOSPHORYLASE B BY ADENOSINE MONOPHOSPHATE |
| 1UZU | A: | GLYCOGEN PHOSPHORYLASE B IN COMPLEX WITH INDIRUBIN-5'-SULPHONATE |
| 2AMV | A: | THE STRUCTURE OF GLYCOGEN PHOSPHORYLASE B WITH AN ALKYL-DIHYDROPYRIDINE-DICARBOXYLIC ACID |
| 2GPA | A: | ALLOSTERIC INHIBITION OF GLYCOGEN PHOSPHORYLASE A BY A POTENTIAL ANTIDIABETIC DRUG |
| 2GPB | A: | COMPARISON OF THE BINDING OF GLUCOSE AND GLUCOSE-1-PHOSPHATE DERIVATIVES TO T-STATE GLYCOGEN PHOSPHORYLASE B |
| 2GPN | A: | 100 K STRUCTURE OF GLYCOGEN PHOSPHORYLASE AT 2.0 ANGSTROMS RESOLUTION |
| 2PRI | A: | BINDING OF 2-DEOXY-GLUCOSE-6-PHOSPHATE TO GLYCOGEN PHOSPHORYLASE B |
| 2PRJ | A: | BINDING OF N-ACETYL-BETA-D-GLUCOPYRANOSYLAMINE TO GLYCOGEN PHOSPHORYLASE B |
| 2SKC | A: | PYRIDOXAL PHOSPHORYLASE B IN COMPLEX WITH FLUOROPHOSPHATE, GLUCOSE AND INOSINE-5'-MONOPHOSPHATE |
| 2SKD | A: | PYRIDOXAL PHOSPHORYLASE B IN COMPLEX WITH PHOSPHATE, GLUCOSE AND INOSINE-5'-MONOPHOSPHATE |
| 2SKE | A: | PYRIDOXAL PHOSPHORYLASE B IN COMPLEX WITH PHOSPHITE, GLUCOSE AND INOSINE-5'-MONOPHOSPHATE |
| 3AMV | A: | ALLOSTERIC INHIBITION OF GLYCOGEN PHOSPHORYLASE A BY A POTENTIAL ANTIDIABETIC DRUG |
| 3GPB | A: | COMPARISON OF THE BINDING OF GLUCOSE AND GLUCOSE-1-PHOSPHATE DERIVATIVES TO T-STATE GLYCOGEN PHOSPHORYLASE B |
| 3SYM | A: | GLYCOGEN PHOSPHORYLASE B IN COMPLEX WITH 3 -C-(HYDROXYMETHYL)-BETA-D-GLUCOPYRANONUCLEOSIDE OF 5-FLUOROURACIL |
| 3SYR | A: | GLYCOGEN PHOSPHORYLASE B IN COMPLEX WITH BETA-D-GLUCOPYRANONUCLEOSIDE 5-FLUOROURACIL |
| 3T3E | A: | GLYCOGEN PHOSPHORYLASE B IN COMPLEX WITH GLCCLU |
| 3T3G | A: | GLYCOGEN PHOSPHORYLASE B IN COMPLEX WITH GLCBRU |
| 3T3H | A: | GLYCOGEN PHOSPHORYLASE B IN COMPLEX WITH GLCIU |
| 3T3I | A: | GLYCOGEN PHOSPHORYLASE B IN COMPLEX WITH GLCCF3U |
| 4EJ2 | A: | CRYSTAL STRUCTURE OF GPB IN COMPLEX WITH DK10 |
| 4EKE | A: | CRYSTAL STRUCTURE OF GPB IN COMPLEX WITH DK11 |
| 4EKY | A: | CRYSTAL STRUCTURE OF GPB IN COMPLEX WITH DK15 |
| 4EL0 | A: | CRYSTAL STRUCTURE OF GPB IN COMPLEX WITH DK16 |
| 4EL5 | A: | CRYSTAL STRUCTURE OF GPB IN COMPLEX WITH DK12 |
| 4GPB | A: | COMPARISON OF THE BINDING OF GLUCOSE AND GLUCOSE-1-PHOSPHATE DERIVATIVES TO T-STATE GLYCOGEN PHOSPHORYLASE B |
| 5GPB | A: | COMPARISON OF THE BINDING OF GLUCOSE AND GLUCOSE-1-PHOSPHATE DERIVATIVES TO T-STATE GLYCOGEN PHOSPHORYLASE B |
| 6GPB | A: | REFINED CRYSTAL STRUCTURE OF THE PHOSPHORYLASE-HEPTULOSE 2-PHOSPHATE-OLIGOSACCHARIDE-AMP COMPLEX |
| 7GPB | A:; B:; C:; D: | STRUCTURAL MECHANISM FOR GLYCOGEN PHOSPHORYLASE CONTROL BY PHOSPHORYLATION AND AMP |
| 8GPB | A: | STRUCTURAL MECHANISM FOR GLYCOGEN PHOSPHORYLASE CONTROL BY PHOSPHORYLATION AND AMP |
| 9GPB | A:; B:; C:; D: | THE ALLOSTERIC TRANSITION OF GLYCOGEN PHOSPHORYLASE |
)
)